Revolution Medicines Inc (RVMD)

12:22 PM

Aug Weekly: Is Revolution Medicines Inc Equity Warrant affected by consumer sentimentDividend Hike & Accurate Trade Setup Notifications - baoquankhu1.vn

12:22 PM

Apr 05, 2026

Jefferies highlights Revolution Medicines, Inc. (RVMD)’s RAS(ON) platform in coverage initiation - MSN

Apr 05, 2026

Apr 04, 2026

Revolution Medicines and Summit Therapeutics Advance Broad RAS(ON) Combo Study in Solid Tumors - TipRanks

Apr 04, 2026

Apr 03, 2026

Revolution Medicines, Inc. (RVMD) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 03, 2026

Apr 03, 2026

Revolution Medicines, Inc. (RVMD) stock price, news, quote and history - Yahoo Finance Singapore

Apr 03, 2026

Apr 03, 2026

Revolution Medicines begins phase 3 pancreatic cancer trial By Investing.com - Investing.com India

Apr 03, 2026

Apr 03, 2026

Revolution Medicines, Inc. (RVMDW) stock price, news, quote and history - Yahoo Finance Singapore

Apr 03, 2026

Apr 02, 2026

Revolution Medicines (RVMD) Begins Phase 3 Trial for Pancreatic Cancer Drug - GuruFocus

Apr 02, 2026

Apr 02, 2026

Wells Fargo Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $144 - Moomoo

Apr 02, 2026

Apr 02, 2026

Revolution Medicines begins phase 3 pancreatic cancer trial - investing.com

Apr 02, 2026

Apr 02, 2026

Revolution Medicines Begins Treating Patients in Phase 3 RASolute 303 Trial Evaluating Daraxonrasib as First Line Treatment for Patients with Metastatic Pancreatic Cancer - The Manila Times

Apr 02, 2026

Apr 02, 2026

First patients enter global Phase 3 test in metastatic pancreatic cancer - Stock Titan

Apr 02, 2026

Apr 02, 2026

Tema Etfs LLC Decreases Position in Revolution Medicines, Inc. $RVMD - MarketBeat

Apr 02, 2026

Apr 01, 2026

A Look At Revolution Medicines (RVMD) Valuation After Recent Share Price Momentum - Yahoo Finance

Apr 01, 2026

Apr 01, 2026

Piper Sandler Maintains Revolution Medicines(RVMD.US) With Buy Rating, Maintains Target Price $120 - Moomoo

Apr 01, 2026

Apr 01, 2026

Behavioral Patterns of RVMD and Institutional Flows - Stock Traders Daily

Apr 01, 2026

Mar 31, 2026

RVMD Stock Price, Quote & Chart | REVOLUTION MEDICINES INC (NASDAQ:RVMD) - ChartMill

Mar 31, 2026

Mar 30, 2026

Revolution Medicines' Readout of Trial for Pancreatic Cancer Drug Likely Positive, Oppenheimer Says - MarketScreener

Mar 30, 2026

Mar 30, 2026

Jefferies Highlights Revolution Medicines, Inc. (RVMD)’s RAS(ON) Platform in Coverage Initiation - Insider Monkey

Mar 30, 2026

Mar 30, 2026

Revolution Medicines (RVMD) price target increased by 10.02% to 136.84 - MSN

Mar 30, 2026

Mar 29, 2026

Is Revolution Medicines, Inc. (RVMD) A Good Stock To Buy Now? - Insider Monkey

Mar 29, 2026

Mar 28, 2026

Revolution Medicines, Inc. (NASDAQ:RVMD) Given Average Rating of "Buy" by Analysts - MarketBeat

Mar 28, 2026

Mar 27, 2026

Revolution Medicines (RVMD) down 8.8% since last earnings report: Can it rebound? - MSN

Mar 27, 2026

Mar 27, 2026

Revolution Medicines (RVMD) Stock: Executive Sells $3.5M While Wall Street Upgrades to Strong-Buy - mexc.co

Mar 27, 2026

Mar 27, 2026

Revolution Medicines (RVMD) Stock Dips as Exec Sells $3.5M — But Analysts Aren’t Flinching - mexc.co

Mar 27, 2026

Mar 27, 2026

Vanguard (RVMD) files amendment showing 0 shares of Revolution Medicines - Stock Titan

Mar 27, 2026

Mar 27, 2026

Revolution Medicines (RVMD) Down 8.8% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Mar 27, 2026

Mar 27, 2026

Revolution Medicines (RVMD) Stock Dips as Exec Sells $3.5M — But Analysts Aren't Flinching - CoinCentral

Mar 27, 2026

Mar 26, 2026

Revolution Medicines exec Mancini sells $3.5m in shares - Investing.com

Mar 26, 2026

Mar 26, 2026

Revolution Medicines exec Mancini sells $3.5m in shares By Investing.com - Investing.com South Africa

Mar 26, 2026

Mar 26, 2026

Revolution Medicines (RVMD) officer exercises options, sells 37,450 shares under 10b5-1 plan - Stock Titan

Mar 26, 2026

Mar 26, 2026

Anthony Mancini of Revolution Medicines (RVMD) details stock options and RSUs - Stock Titan

Mar 26, 2026

Mar 26, 2026

Revolution Medicines (RVMD) CDO details initial option and RSU stake - Stock Titan

Mar 26, 2026

Mar 26, 2026

Revolution Medicines outlines $1.03B–$1.09B net loss guidance for 2025 amid expanded global RAS portfolio strategy - MSN

Mar 26, 2026

Mar 26, 2026

Revolution Medicines (NASDAQ:RVMD) Upgraded by Truist Financial to Strong-Buy Rating - MarketBeat

Mar 26, 2026

Mar 26, 2026

[144] Revolution Medicines, Inc. SEC Filing - Stock Titan

Mar 26, 2026

Mar 25, 2026

MIL:1RVMD PB Ratio: 12.09 — 225% Above Median - GuruFocus

Mar 25, 2026

Mar 25, 2026

Merck's $6.7 Billion Terns Pharmaceuticals Acquisition May Face Rival Interest: Analyst - Benzinga

Mar 25, 2026

Mar 22, 2026

Wedbush Reiterates Revolution Medicines (RVMD) Outperform Recommendation - MSN

Mar 22, 2026

Mar 22, 2026

Insider Selling: Revolution Medicines (NASDAQ:RVMD) Insider Sells $427,962.96 in Stock - Defense World

Mar 22, 2026

Mar 22, 2026

Revolution Medicines (NASDAQ:RVMD) CFO Sells $273,868.44 in Stock - Defense World

Mar 22, 2026

Mar 21, 2026

(RVMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily

Mar 21, 2026

Mar 20, 2026

Revolution Medicines, Inc.: Fundamental Analysis and Financial Ratings | 1RVMD | US76155X1000 - marketscreener.com

Mar 20, 2026

Mar 20, 2026

Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating - MSN

Mar 20, 2026

Mar 20, 2026

A Look At Revolution Medicines (RVMD) Valuation After AACR RAS(ON) Pipeline Data Catalyst - simplywall.st

Mar 20, 2026

Mar 20, 2026

Revolution Medicines COO Horn sells $455,918 in shares By Investing.com - Investing.com South Africa

Mar 20, 2026

Mar 20, 2026

Revolution Medicines Eyes Guidance with Mixed Signals from Financial Reports - timothysykes.com

Mar 20, 2026